Skip to content

Prognostic Prediction of NPC Based on MR Diffusion-weighted Imaging

Prognostic Prediction of Nasopharyngeal Carcinoma Based on Radiomics Features of MR Diffusion-weighted Imaging

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05112510
Enrollment
125
Registered
2021-11-09
Start date
2021-06-01
Completion date
2022-06-01
Last updated
2021-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Nasopharyngeal Carcinoma

Brief summary

The purpose of this study is to explore whether the imaging model based on RESOLVE-DWI sequence can exploiting the heterogeneity of nasopharyngeal carcinoma and indicate the prognosis, so as to provide intervention information for clinical decision-making. All patients were randomly divided into the training group and the validation group. Radiomics features extracted from T2-weighted, DWI, apparent diffusion coefficient (ADC), and contrast- enhanced T1-weighted were used to build a radiomics model. Patients'clinical variables were also obtained to build a clinical model. Model of training cohort was established using cross-validation for nasopharyngeal carcinoma prognosis by machine learning, including Logistics Regression, SVM, KNN, Decision Tree, Random Forest, XGBoost, and then, the model will be verified in the validation cohort. Area under the curve (AUC) of the Machine learning model was used as the main evaluation metric.

Interventions

OTHERObserving whether developing distant metastasis or recurrence

The study is a observational study and has no intervention.

Sponsors

Fifth Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. patients with nasopharyngeal carcinoma diagnosed by pathology; 2. complete clinical data and MR imaging data; 3. without radiotherapy, chemotherapy or operation before MR examination.

Exclusion criteria

1. incomplete follow-up data; 2. poor image quality and can not be used for analysis; 3. patients with other tumors in the past or at the same time.

Design outcomes

Primary

MeasureTime frameDescription
Calculating AUC of machine learning model based on MR diffusion-weighted imaging to evaluate efficacy for prognosisBefore January 2022After building machine learning model based on the features extracted by MR diffusion-weighted imaging of patients with nasopharyngeal carcinoma. Some measurements will be output from machine learning model such as AUC、F1、Accuracy and so on. Area under the curve (AUC) of the Machine learning model will be used as the main evaluation metric to evaluate the efficacy of a machine learning model which is used to predict the prognosis of patients with nasopharyngeal carcinoma (NPC).

Secondary

MeasureTime frameDescription
Comparing AUC of machine learning model based on MR diffusion-weighted imaging and conventional MR sequences for prognosisBefore January 2022After separately building machine learning model based on the highly correlated features extracted by MR diffusion-weighted imaging and conventional MR sequences of patients with nasopharyngeal carcinoma. Some measurements will be output from the machine learning models such as AUC、F1、Accuracy and so on. Area under the curve (AUC) of the Machine learning model will be used as the main evaluation metric to study if the prediction efficiency of the machine learning model based on the highly correlated features extracted by MR diffusion weighted imaging imaging is better than that of conventional MR sequences.
Calculating AUC of machine learning model based on MR diffusion-weighted imaging combinated with conventional MR sequence to evaluate efficacy for prognosisBefore January 2022Fianlly, we build a machine learning model based on MR diffusion-weighted imaging combinated with conventional MR sequences from patients with nasopharyngeal carcinoma. Some measurements will be output from the machine learning models such as AUC、F1、Accuracy and so on. Area under the curve (AUC) of the Machine learning model will be used as the main evaluation metric to explore whether the machine learning model established by imaging features of MR diffusion-weighted imaging and conventional MR sequence has best prediction efficiency comparing with the models mentioned above.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026